StockData
Filana Therapeutics, Inc. logo

Filana Therapeutics, Inc. (FLNA) stock

FLNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$0.64+0.08 (+14.52%)

Close on Nov 20, 2026Market cap $30.98MP/E –Yield –

Filana Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2013 it was $41.12M, up 277.6% from the year before. The highest annual figure on record is $41.12M in fiscal 2013.

Annual revenue

PeriodPeriod endValueChange
FY2013Dec 31, 2013$41.12M+277.6%
FY2012Dec 31, 2012$10.89M-5.2%
FY2011Dec 31, 2011$11.48M-31.7%
FY2010Dec 31, 2010$16.81M-18.3%
FY2009Dec 31, 2009$20.56M–

More Filana Therapeutics figures

See a number that looks wrong?